Brammer Biopharmaceuticals Overview
- Founded
-
2015
- Status
-
Acquired/Merged
- Employees
-
350
- Latest Deal Type
-
Buyout/LBO
- Financing Rounds
-
1
- Investments
-
1
Brammer Biopharmaceuticals General Information
Description
Provider of best-in-class cell and gene therapy designed to improve patient health. The company's cell and gene therapy enabling pharmaceuticals and biotech clients to accelerate the delivery of novel medicines.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly PE-Backed
Primary Industry
Biotechnology
Acquirer
Primary Office
- PO Box 267
- Lexington, MA 02420
- United States
Brammer Biopharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Brammer Biopharmaceuticals Executive Team (2)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Mark Bamforth | Co-Founder, President & Chief Executive Officer |
Brammer Biopharmaceuticals Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
Brammer Biopharmaceuticals Acquisitions (1)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 000000 (00000 | 01-Jan-2017 | 0000000000 | Buildings and Property |